712 related articles for article (PubMed ID: 23446951)
1. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of 25(OH)D are not associated with venous thromboembolism in the elderly population. A case-control study.
Andro M; Delluc A; Moineau MP; Tromeur C; Gouillou M; Lacut K; Carré JL; Gentric A; Le Gal G
Thromb Haemost; 2016 Jan; 115(1):169-75. PubMed ID: 26538494
[TBL] [Abstract][Full Text] [Related]
3. Body height and risk of venous thromboembolism: The Tromsø Study.
Braekkan SK; Borch KH; Mathiesen EB; Njølstad I; Wilsgaard T; Hansen JB
Am J Epidemiol; 2010 May; 171(10):1109-15. PubMed ID: 20418276
[TBL] [Abstract][Full Text] [Related]
4. Associations between serum levels of calcium, parathyroid hormone and future risk of venous thromboembolism: the Tromsø study.
Lerstad G; Brodin EE; Svartberg J; Jorde R; Brox J; Brækkan SK; Hansen JB
Eur J Endocrinol; 2017 May; 176(5):625-634. PubMed ID: 28246149
[TBL] [Abstract][Full Text] [Related]
5. A combination of low serum concentrations of vitamins K1 and D is associated with increased risk of hip fractures in elderly Norwegians: a NOREPOS study.
Finnes TE; Lofthus CM; Meyer HE; Søgaard AJ; Tell GS; Apalset EM; Gjesdal C; Grimnes G; Schei B; Blomhoff R; Samuelsen SO; Holvik K
Osteoporos Int; 2016 Apr; 27(4):1645-1652. PubMed ID: 26630974
[TBL] [Abstract][Full Text] [Related]
6. Thyroid function, as assessed by TSH, and future risk of venous thromboembolism: the Tromsø study.
Lerstad G; Enga KF; Jorde R; Brodin EE; Svartberg J; Brækkan SK; Hansen JB
Eur J Endocrinol; 2015 Jul; 173(1):83-90. PubMed ID: 25899580
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia, assessed according to HbA1c , and future risk of venous thromboembolism: the Tromsø study.
Lerstad G; Brodin EE; Enga KF; Jorde R; Schirmer H; Njølstad I; Svartberg J; Braekkan SK; Hansen JB
J Thromb Haemost; 2014; 12(3):313-9. PubMed ID: 24382156
[TBL] [Abstract][Full Text] [Related]
8. 25-Hydroxyvitamin D concentrations and risk of venous thromboembolism in the general population with 18,791 participants.
Brøndum-Jacobsen P; Benn M; Tybjaerg-Hansen A; Nordestgaard BG
J Thromb Haemost; 2013 Mar; 11(3):423-31. PubMed ID: 23279309
[TBL] [Abstract][Full Text] [Related]
9. Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up.
Grimnes G; Emaus N; Joakimsen RM; Figenschau Y; Jenssen T; Njølstad I; Schirmer H; Jorde R
Diabet Med; 2010 Oct; 27(10):1107-15. PubMed ID: 20854377
[TBL] [Abstract][Full Text] [Related]
10. Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population.
Ellingsen TS; Lappegård J; Skjelbakken T; Brækkan SK; Hansen JB
Thromb Haemost; 2015 Jan; 113(1):193-200. PubMed ID: 25274492
[TBL] [Abstract][Full Text] [Related]
11. Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study.
Hald EM; Lijfering WM; Mathiesen EB; Johnsen SH; Løchen ML; Njølstad I; Wilsgaard T; Rosendaal FR; Brækkan SK; Hansen JB
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):226-30. PubMed ID: 24177328
[TBL] [Abstract][Full Text] [Related]
12. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, Tromsø, Norway.
Braekkan SK; Mathiesen EB; Njølstad I; Wilsgaard T; Størmer J; Hansen JB
J Thromb Haemost; 2010 Jan; 8(1):157-62. PubMed ID: 19496920
[TBL] [Abstract][Full Text] [Related]
13. Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study.
Svartberg J; Braekkan SK; Laughlin GA; Hansen JB
Eur J Endocrinol; 2009 May; 160(5):833-8. PubMed ID: 19208774
[TBL] [Abstract][Full Text] [Related]
14. Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.
Rinde LB; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Hald EM; Wilsgaard T; Brækkan SK; Hansen JB
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821402
[TBL] [Abstract][Full Text] [Related]
15. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.
Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH;
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935
[TBL] [Abstract][Full Text] [Related]
16. Serum Vitamin D Status as a Predictor of Prognosis in Patients with Acute Ischemic Stroke.
Park KY; Chung PW; Kim YB; Moon HS; Suh BC; Won YS; Kim JM; Youn YC; Kwon OS
Cerebrovasc Dis; 2015; 40(1-2):73-80. PubMed ID: 26184826
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study.
Enga KF; Braekkan SK; Hansen-Krone IJ; le Cessie S; Rosendaal FR; Hansen JB
J Thromb Haemost; 2012 Oct; 10(10):2068-74. PubMed ID: 22882779
[TBL] [Abstract][Full Text] [Related]
18. Heart healthy diet and risk of myocardial infarction and venous thromboembolism. The Tromsø Study.
Hansen-Krone IJ; Enga KF; Njølstad I; Hansen JB; Braekkan SK
Thromb Haemost; 2012 Sep; 108(3):554-60. PubMed ID: 22739999
[TBL] [Abstract][Full Text] [Related]
19. Serum 25(OH)D and incident type 2 diabetes: a cohort study.
Husemoen LL; Skaaby T; Thuesen BH; Jørgensen T; Fenger RV; Linneberg A
Eur J Clin Nutr; 2012 Dec; 66(12):1309-14. PubMed ID: 23031851
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.
Ginde AA; Scragg R; Schwartz RS; Camargo CA
J Am Geriatr Soc; 2009 Sep; 57(9):1595-603. PubMed ID: 19549021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
